Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2005 Jan;90(1):F31–F35. doi: 10.1136/adc.2003.035790

Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial

J Schulte, J Osborne, J Benson, R Cooke, M Drayton, J Murphy, J Rennie, B Speidel
PMCID: PMC1721806  PMID: 15613570

Abstract

Objective: To compare neurodevelopmental outcome of survivors of the multicentre trial of etamsylate (the iRNN for ethamsylate) for prevention of periventricular haemorrhage in very low birthweight infants.

Design: Double blind, single observer, prospective follow up of placebo controlled study.

Setting: Six neonatal intensive care units in the United Kingdom. Neurodevelopmental outcome was assessed in health premises or children's homes.

Subjects: 268 of 276 survivors of the original study were seen between 3.5 and 4.2 years of age. All were inborn and weighed 1500 g or less at birth.

Intervention: Etamsylate 12.5 mg/kg or placebo six hourly from within one hour of delivery for four days.

Main outcome measures: McCarthy scales of children's abilities, standardised neurological examination, full physical examination, functional assessment, seven letter Stycar vision test, and audiometry.

Results: There was no difference between the groups in neuromotor outcome (cerebral palsy) or in the general cognitive index (GCI) of the McCarthy scales (mean GCI was 93.3 for the etamsylate group (n  =  133) and 89.7 for the placebo group (n  =  131); p  =  0.10). There were more children with GCI < 70 (9 v 19; p  =  0.047) or ⩽ 50 (3 v 11; p  =  0.03) in the placebo group. Fewer children in the etamsylate group had squints (17 v 30; p  =  0.042) or required surgery for patent ductus arteriosus (1 v 8; p  =  0.036).

Conclusions: Etamsylate was not associated with a reduction in cerebral palsy. Severe cognitive impairment was reduced, but more children died and the improvement may be because fewer survived with low GCI.

Full Text

The Full Text of this article is available as a PDF (73.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson J. W., Drayton M. R., Hayward C., Murphy J. F., Osborne J. P., Rennie J. M., Schulte J. F., Speidel B. D., Cooke R. W. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet. 1986 Dec 6;2(8519):1297–1300. doi: 10.1016/s0140-6736(86)91432-7. [DOI] [PubMed] [Google Scholar]
  2. Catto-Smith A. G., Yu V. Y., Bajuk B., Orgill A. A., Astbury J. Effect of neonatal periventricular haemorrhage on neurodevelopmental outcome. Arch Dis Child. 1985 Jan;60(1):8–11. doi: 10.1136/adc.60.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen J. Y. Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants. J Formos Med Assoc. 1993 Oct;92(10):889–893. [PubMed] [Google Scholar]
  4. Costello A. M., Hamilton P. A., Baudin J., Townsend J., Bradford B. C., Stewart A. L., Reynolds E. O. Prediction of neurodevelopmental impairment at four years from brain ultrasound appearance of very preterm infants. Dev Med Child Neurol. 1988 Dec;30(6):711–722. doi: 10.1111/j.1469-8749.1988.tb14633.x. [DOI] [PubMed] [Google Scholar]
  5. Elbourne D., Ayers S., Dellagrammaticas H., Johnson A., Leloup M., Lenoir-Piat S., EC Ethamsylate Trial Group Randomised controlled trial of prophylactic etamsylate: follow up at 2 years of age. Arch Dis Child Fetal Neonatal Ed. 2001 May;84(3):F183–F187. doi: 10.1136/fn.84.3.F183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Graham M., Levene M. I., Trounce J. Q., Rutter N. Prediction of cerebral palsy in very low birthweight infants: prospective ultrasound study. Lancet. 1987 Sep 12;2(8559):593–596. doi: 10.1016/s0140-6736(87)92986-2. [DOI] [PubMed] [Google Scholar]
  7. Griffith H. B., Jamjoom A. B. The treatment of childhood hydrocephalus by choroid plexus coagulation and artificial cerebrospinal fluid perfusion. Br J Neurosurg. 1990;4(2):95–100. doi: 10.3109/02688699008992706. [DOI] [PubMed] [Google Scholar]
  8. Levene M. I. Cerebral ultrasound and neurological impairment: telling the future. Arch Dis Child. 1990 May;65(5):469–471. doi: 10.1136/adc.65.5.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ment L. R., Duncan C. C., Ehrenkranz R. A., Lange R. C., Taylor K. J., Kleinman C. S., Scott D. T., Sivo J., Gettner P. Intraventricular hemorrhage in the preterm neonate: timing and cerebral blood flow changes. J Pediatr. 1984 Mar;104(3):419–425. doi: 10.1016/s0022-3476(84)81109-9. [DOI] [PubMed] [Google Scholar]
  10. Mutch L. M., Johnson M. A., Morley R. Follow up studies: design, organisation, and analysis. Arch Dis Child. 1989 Oct;64(10 Spec No):1394–1402. doi: 10.1136/adc.64.10_spec_no.1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Palmer P., Dubowitz L. M., Levene M. I., Dubowitz V. Developmental and neurological progress of preterm infants with intraventricular haemorrhage and ventricular dilatation. Arch Dis Child. 1982 Oct;57(10):748–753. doi: 10.1136/adc.57.10.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Papile L. A., Munsick-Bruno G., Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr. 1983 Aug;103(2):273–277. doi: 10.1016/s0022-3476(83)80366-7. [DOI] [PubMed] [Google Scholar]
  13. Perlman J. M., Hill A., Volpe J. J. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr. 1981 Nov;99(5):767–771. doi: 10.1016/s0022-3476(81)80408-8. [DOI] [PubMed] [Google Scholar]
  14. Raichle M. E. The pathophysiology of brain ischemia. Ann Neurol. 1983 Jan;13(1):2–10. doi: 10.1002/ana.410130103. [DOI] [PubMed] [Google Scholar]
  15. Stewart A. L., Reynolds E. O., Hope P. L., Hamilton P. A., Baudin J., Costello A. M., Bradford B. C., Wyatt J. S. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Dev Med Child Neurol. 1987 Feb;29(1):3–11. doi: 10.1111/j.1469-8749.1987.tb02101.x. [DOI] [PubMed] [Google Scholar]
  16. Stewart A. L., Thorburn R. J., Hope P. L., Goldsmith M., Lipscomb A. P., Reynolds E. O. Ultrasound appearance of the brain in very preterm infants and neurodevelopmental outcome at 18 months of age. Arch Dis Child. 1983 Aug;58(8):598–604. doi: 10.1136/adc.58.8.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tin W., Fritz S., Wariyar U., Hey E. Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty. Arch Dis Child Fetal Neonatal Ed. 1998 Sep;79(2):F83–F87. doi: 10.1136/fn.79.2.f83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wigglesworth J. S., Pape K. E. An integrated model for haemorrhagic and ischaemic lesions in the newborn brain. Early Hum Dev. 1978 Jul;2(2):179–199. doi: 10.1016/0378-3782(78)90010-5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES